Trial intelligence / Profile preview

Duloxetine for pain and quality of recovery after rotator cuff repair

ChiCTR2000035105Phase 4Recruiting

Sponsor
West China Hospital of Sichuan University
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of duloxetine in Rotator cuff deficiency (RCD) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Postoperative pain. Started Aug 2020; status: recruiting.

02

Drugs

duloxetine
03

Conditions

Rotator cuff deficiency (RCD)

Beyond the preview

Go deeper on ChiCTR2000035105.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000035105.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call